Helen Murray Free Dies at 98; Chemist Developed Diabetes Test
Helen Murray Free, a chemist who co-developed the revolutionary dip-and-read diabetes test that simplified diagnosis and inspired other similar testing, has died.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Diabetes & Metabolic Diseases |
Helen Murray Free, a chemist who co-developed the revolutionary dip-and-read diabetes test that simplified diagnosis and inspired other similar testing, has died.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Covid 19 |
Urine analysis of COVID-19 patients revealed elevated levels of specific biomarkers of the immune system compared to those who were not infected with the coronavirus.
Read MorePosted by Melanie Hamilton-Basich | May 3, 2021 | Immunoassay |
Roche announced five new intended uses for two key cardiac biomarkers using the Elecsys technology: high sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide test.
Read MorePosted by Melanie Hamilton-Basich | Apr 27, 2021 | Flow Cytometry |
University of Birmingham spinout ChromaTwist, Birmingham, UK, has secured £300k of seed funding to develop a new class of fluorescent materials for use in bio-sensing and bio-imaging tests for diseases such as cancer and diabetes.
Read MorePosted by Laurie Bonner | Mar 26, 2021 | Disease States |
Early detection, monitoring, and noninvasive diagnostic testing are essential to controlling this epidemic.
Read More